Literature DB >> 15863453

Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome.

N Muenter Swift1, N Charkoudian, R M Dotson, G A Suarez, P A Low.   

Abstract

Postural orthostatic tachycardia syndrome (POTS) is characterized by excessive tachycardia during orthostasis. To test the hypothesis that patients with POTS have decreased sympathetic neural responses to baroreflex stimuli, we measured heart rate (HR) and muscle sympathetic nerve activity (MSNA) responses to three baroreflex stimuli including vasoactive drug boluses (modified Oxford technique), Valsalva maneuver, and head-up tilt (HUT) in POTS patients and healthy control subjects. The MSNA response to the Valsalva maneuver was significantly greater in the POTS group (controls, 26 +/- 7 vs. POTS, 48 +/- 6% of baseline MSNA/mmHg; P = 0.03). POTS patients also had an exaggerated MSNA response to 30 degrees HUT (controls, 123 +/- 24 vs. POTS, 208 +/- 30% of baseline MSNA; P = 0.03) and tended to have an exaggerated response to 45 degrees HUT (controls, 137 +/- 27 vs. POTS, 248 +/- 58% of baseline MSNA; P = 0.10). Sympathetic baroreflex sensitivity calculated during administration of the vasoactive drug boluses also tended to be greater in the POTS patients; however, this did not reach statistical significance (P = 0.15). Baseline MSNA values during supine rest were not different between the groups (controls, 23 +/- 4 vs. POTS, 16 +/- 5 bursts/100 heartbeats; P = 0.30); however, resting HR was significantly higher in the POTS group (controls, 58 +/- 3 vs. POTS, 82 +/- 4 beats/min; P = 0.0001). Our results suggest that POTS patients have exaggerated MSNA responses to baroreflex challenges compared with healthy control subjects, although resting supine MSNA values did not differ between the groups.

Entities:  

Mesh:

Year:  2005        PMID: 15863453     DOI: 10.1152/ajpheart.01243.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

1.  Effects of exercise training on arterial-cardiac baroreflex function in POTS.

Authors:  M Melyn Galbreath; Shigeki Shibata; Tiffany B VanGundy; Kazunobu Okazaki; Qi Fu; Benjamin D Levine
Journal:  Clin Auton Res       Date:  2010-11-20       Impact factor: 4.435

2.  Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome.

Authors:  Jordan A Brewster; Emily M Garland; Italo Biaggioni; Bonnie K Black; John F Ling; Cyndya A Shibao; David Robertson; Satish R Raj
Journal:  Clin Sci (Lond)       Date:  2012-01       Impact factor: 6.124

Review 3.  Postural orthostatic tachycardia syndrome.

Authors:  A K Agarwal; R Garg; A Ritch; P Sarkar
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

4.  Postural orthostatic tachycardia syndrome (POTS).

Authors:  Bharat Sidhu; Nonyelum Obiechina; Noman Rattu; Shanta Mitra
Journal:  BMJ Case Rep       Date:  2013-09-16

5.  Distal sudomotor findings in postural tachycardia syndrome.

Authors:  Amanda Catherine Peltier; Emily Garland; Satish R Raj; Kyoko Sato; Bonnie Black; Yanna Song; Lily Wang; Italo Biaggioni; Andre Diedrich; David Robertson
Journal:  Clin Auton Res       Date:  2009-12-25       Impact factor: 4.435

6.  Neuronal source of plasma dopamine.

Authors:  David S Goldstein; Courtney Holmes
Journal:  Clin Chem       Date:  2008-09-18       Impact factor: 8.327

Review 7.  Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

Authors:  Michael Gutkin; Julian M Stewart
Journal:  Am J Hypertens       Date:  2016-04-01       Impact factor: 2.689

8.  Abnormalities of angiotensin regulation in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Emily M Garland; Italo Biaggioni; Bonnie K Black; William D Dupont; David Robertson; Satish R Raj
Journal:  Heart Rhythm       Date:  2011-01-22       Impact factor: 6.343

Review 9.  POTS versus deconditioning: the same or different?

Authors:  Michael J Joyner; Shizue Masuki
Journal:  Clin Auton Res       Date:  2008-08-12       Impact factor: 4.435

10.  Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.

Authors:  Adil E Bharucha; Nisha Charkoudian; Christopher N Andrews; Michael Camilleri; David Sletten; Alan R Zinsmeister; Phillip A Low
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-02       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.